Ashlan J. Kunz Coyne (@ashlan_kunz) 's Twitter Profile
Ashlan J. Kunz Coyne

@ashlan_kunz

Asst Professor of Translational Research @UK_COP

ID: 4786317557

calendar_today12-01-2016 17:46:13

900 Tweet

328 Takipçi

199 Takip Edilen

University of Kentucky College of Pharmacy (@uk_cop) 's Twitter Profile Photo

🚨 New Publication Alert Science Magazine Translational Medicine has featured a new study led by Dr. Caroline Geisler, assistant professor at University of Kentucky College of Pharmacy, on a novel brain-targeting approach to obesity treatment. Current weight loss drugs like GLP-1 receptor agonists (e.g.,

🚨 New Publication Alert

<a href="/ScienceMagazine/">Science Magazine</a> Translational Medicine has featured a new study led by Dr. Caroline Geisler, assistant professor at <a href="/UK_COP/">University of Kentucky College of Pharmacy</a>, on a novel brain-targeting approach to obesity treatment.

Current weight loss drugs like GLP-1 receptor agonists (e.g.,
Ashlan J. Kunz Coyne (@ashlan_kunz) 's Twitter Profile Photo

This publication is different. I began it 3 months postpartum, when my mind and body felt unfamiliar. Slowly, I found joy in writing again. Seeing it published as an Editor’s Choice is deeply meaningful. Grateful to the Kunz Coyne Lab for their support.

Open Forum Infectious Diseases (@ofidjournal) 's Twitter Profile Photo

Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia ✅ Just Accepted bit.ly/3HegV0y

UK Research (@researchky) 's Twitter Profile Photo

University of Kentucky College of Pharmacy researcher Caroline Geisler and her team recently explored whether a signaling system in the brain could be targeted to achieve weight loss and blood sugar control without triggering the side effects that often accompany popular GLP-1 medications. research.uky.edu/news/qa-caroli…

University of Kentucky College of Pharmacy (@uk_cop) 's Twitter Profile Photo

A New Weight Loss Path…Minus the Nausea? 👩🏻‍🔬 Current GLP-1 drugs like Ozempic® and Wegovy® are highly effective, but side effects such as nausea and vomiting lead many patients to stop treatment. In a new Q&A, Caroline Geisler (assistant professor) discusses early-stage research

A New Weight Loss Path…Minus the Nausea? 👩🏻‍🔬

Current GLP-1 drugs like Ozempic® and Wegovy® are highly effective, but side effects such as nausea and vomiting lead many patients to stop treatment. In a new Q&amp;A, Caroline Geisler (assistant professor) discusses early-stage research
University of Kentucky College of Pharmacy (@uk_cop) 's Twitter Profile Photo

New Pub Alert 🚨 Dr. Kunz Coyne (Ashlan J. Kunz Coyne) and the Kunz Coyne Lab are authors of a newly published study in Open Forum Infectious Diseases (OFID), the journal of the Infectious Diseases Society of America (IDSA), titled “Propensity-Matched Comparison of Timely vs. Delayed

New Pub Alert 🚨

Dr. Kunz Coyne (<a href="/Ashlan_Kunz/">Ashlan J. Kunz Coyne</a>) and the Kunz Coyne Lab are authors of a newly published study in Open Forum Infectious Diseases (OFID), the journal of the Infectious Diseases Society of America (IDSA), titled “Propensity-Matched Comparison of Timely vs. Delayed
Open Forum Infectious Diseases (@ofidjournal) 's Twitter Profile Photo

Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia ✅ Just Accepted doi.org/10.1093/ofid/o…

UK Research (@researchky) 's Twitter Profile Photo

A new study from University of Kentucky Martin-Gatton CAFE reveals that antibiotic resistance in cattle-associated bacteria could have far-reaching implications for human, animal and environmental health. research.uky.edu/news/uk-study-…

University of Kentucky College of Pharmacy (@uk_cop) 's Twitter Profile Photo

💡 Could a chatbot be your next teaching assistant? AACP's Technology in Pharmacy Education and Learning SIG awarded Jeff Cain and Aishwarya Rajan (PharmD ’24) with the 2025 Publication Award. 🏆 Their article, Proof of Concept of ChatGPT as a Virtual Tutor, published

💡 Could a chatbot be your next teaching assistant?

<a href="/AACPharmacy/">AACP</a>'s Technology in Pharmacy Education and Learning SIG awarded <a href="/DrJeffCain/">Jeff Cain</a> and Aishwarya Rajan (PharmD ’24) with the 2025 Publication Award. 🏆

Their article, Proof of Concept of ChatGPT as a Virtual Tutor, published
Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

New episode alert! 7 PM Antibiotics: What’s New 💊🧫 From cefepime–enmetazobactam to sulopenem and tebipenem Ashlan J. Kunz Coyne joins me to unpack the latest antibiotics, share key clinical insights, and talk stewardship strategies for tackling resistance. #letstalkmicro

Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

Happy Friday! 🎉 A new episode just dropped: ESBL, UTIs & new antibiotics 💊🦠 What’s new? 🎙️ Link in comments. #microbiology #podcast #ESBL #UTI #antibiotics Ashlan J. Kunz Coyne

Happy Friday! 🎉
A new episode just dropped: ESBL, UTIs &amp; new antibiotics 💊🦠
What’s new? 🎙️ Link in comments.

#microbiology #podcast #ESBL #UTI #antibiotics

<a href="/Ashlan_Kunz/">Ashlan J. Kunz Coyne</a>
Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

Episose alert: Why wait 24 hours for AST? ⏳ Drs. Osborn & Dien Bard discuss how early growth isolates could provide faster AST results—without extra cost or equipment. 🎙️ Episode: Early Growth, Faster Answers: Rethinking AST 7 PM EST Lucas Osborn, PhD, D(ABMM) #letstakmicro #podcast

Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

🎉 Happy Friday! The latest episode is out! Faster AST results—18 hours sooner ⏱️ Drs. Jenn Dien Bard & Lucas Osborn explain early growth AST & what it means for labs + patients. 🎙️ Listen here: directory.libsyn.com/episode/index/… Lucas Osborn, PhD, D(ABMM)

Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

🎙️ Episode Alert! We’re revisiting early growth disk diffusion with Dr. Carey-Ann Burnham, Dr. Daniel Webber, and Meghan Wallace. Can AST results be delivered faster using just 6 hour growth? #LetsTalkMicro #AST #Microbiology #podcast

🎙️ Episode Alert!
We’re revisiting early growth disk diffusion with Dr. Carey-Ann Burnham, Dr. Daniel Webber, and Meghan Wallace. Can AST results be delivered faster using just 6 hour growth?

#LetsTalkMicro #AST #Microbiology #podcast
Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

💊 Sulopenem FDA approval: for adult women with uncomplicated UTIs (E. coli, K. pneumoniae, P. mirabilis) — only when other options are limited. 🎙️ Hear Dr. Ashlan Kunz Coyne explain more in Let’s Talk Micro. 👉 asm.org/podcasts/lets-… Ashlan J. Kunz Coyne

ACCP INFD PRN (@accpinfdprn) 's Twitter Profile Photo

Join the ACCP ID PRN for Acing That Interview – tips for navigating residency, fellowship, or job interviews.🤝 Date: 9/4 | Time: 4–5 PM EST | Virtual 💻 Refer to ID PRN listserv email 📩to register and Zoom link.

Join the ACCP ID PRN for Acing That Interview – tips for navigating residency, fellowship, or job interviews.🤝

Date: 9/4 | Time: 4–5 PM EST | Virtual 💻

Refer to ID PRN listserv email 📩to register and Zoom link.
Letstalkmicro (@letstalkmicro1) 's Twitter Profile Photo

🦠 Outbreak detection saves lives & costs. Early action can stop outbreaks, prevent infections, and reduce hospital burden. 🎙️ Hear more in Let’s Talk Micro: asm.org/podcasts/lets-… #OutbreakDetection #LetsTalkMicro #Microbiology